Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Corium and Lotus Pharmaceutical Form Exclusive Licence Agreement for ADLARITY®

Friday, August 11, 2023

Corium and Lotus Pharmaceuti announced that they have entered into an exclusive collaboration and licence agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia.

Under the terms of the agreement, Lotus seems to have exclusive rights to commercialise ADLARITY® in the mentioned countries, and they will also be responsible for handling the regulatory approval process in those countries. The applicable territories include Taiwan, South Korea, Hong Kong, Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam.

This partnership marks a significant achievement in the development and delivery of innovative therapies aimed at offering healthcare professionals essential treatment choices for patients, as well as their families and caregivers.

ADLARITY®, with its distinctive approach, offers a notable advancement in care that has the potential to greatly enhance the quality of life for individuals affected by Alzheimer's disease. ADLARITY® has received approval from the U.S. Food and Drug Administration (FDA) for use in the United States. It is the pioneering and sole once-weekly patch endorsed by the FDA for addressing mild, moderate, and severe dementia associated with Alzheimer's disease.

The transdermal system not only employs proprietary CorplexTM technology to ensure a consistent and gradual release of donepezil through the skin, but it also circumvents the need for passage through the gastrointestinal tract. This unique approach helps minimise the likelihood of gastrointestinal side effects.a

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024